Wockhardt Gets Another FDA Warning Letter Over GMP Deficiencies

Drug Industry Daily
A A
CP Pharmaceuticals, a subsidiary of drug manufacturer Wockhardt Limited received a warning letter that inspection of its facility revealed significant GMP violations.

To View This Article:

Login

Subscribe To Drug Industry Daily